成人肥胖与严重感染风险:多队列研究及全球负担估计
该多队列研究基于芬兰两个队列和英国生物银行数据,分析BMI与925种感染性疾病发病、住院和死亡风险的关联。
要点
- III级肥胖者感染相关住院和死亡风险约为健康体重者的3倍。
- 全球约十分之一的感染相关死亡可能归因于肥胖。
核心结论
- 成人肥胖是多种病原体所致感染相关住院和死亡的风险因素。
- 全球约十分之一的感染相关死亡可能归因于肥胖。
研究设计与样本
- 基线评估BMI并分类为健康体重、超重及肥胖I-III级,随访感染相关住院和死亡。
- 利用风险比和全球疾病负担数据估计2018、2021、2023年归因于肥胖的感染死亡比例。
临床怎么用
- 在感染性疾病风险评估和预防中,应将肥胖视为可干预的危险因素。
- 对肥胖成人,尤其是III级肥胖者,需加强感染监测和预防措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adult obesity has been linked to specific infections, but evidence across the full spectrum of infectious diseases remains scarce. In this multicohort study with impact modelling, we examined the association between this preventable risk factor and the incidence, hospitalisations, and mortality of 925 bacterial, viral, parasitic, and fungal infectious diseases, and estimated their global and regional attributable impact. METHODS: We used pooled data from two Finnish cohort studies and repeated analyses in an independent population from the UK Biobank. BMI was assessed at baseline (1998-2002 in the Finnish studies; 2006-10 in UK Biobank), and participants were categorised as having healthy weight (18·5-24·9 kg/m2), overweight (25·0-29·9 kg/m2) or obesity, classified as class I (30·0-34·9 kg/m2), class II (35·0-39·9 kg/m2), or class III (≥40·0 kg/m2). Participants were followed up through national hospitalisation and mortality registries for hospital admissions and deaths due to infectious diseases. Using hazard ratios derived from the Finnish cohorts and UK Biobank, along with obesity prevalence estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study database, we estimated the proportion of fatal infections attributable to obesity globally, regionally, and by country for the years 2018 (before), 2021 (during), and 2023 (after the COVID-19 pandemic). FINDINGS: The analysis included 67 766 adults (mean age 42·1 [SD 10·8] years; 49 516 [73·1%] females, 18 250 [26·9%] males) from the Finnish cohorts and 479 498 adults (mean age 57·0 [SD 8·1] years; 261 084 [54·4%] females, 218 414 [45·6%] males) from UK Biobank. Participants had no recent history of infection-related hospitalisations at baseline. During follow-up, there were 8230 incident infection cases in the Finnish cohorts and 81 945 in UK Biobank. Compared with individuals of healthy weight, those with class III obesity had a three-times higher risk of infection-related hospital admissions (Finnish cohorts 2·75 [95% CI 2·24-3·37], UK Biobank 3·07 [2·95-3·19]), death (Finnish cohorts 3·06 [1·25-7·49], UK Biobank 3·54 [3·15-3·98]), or either outcome (Finnish cohorts 2·69 [2·19-3·30], UK Biobank 3·07 [2·95-3·19]). The corresponding pooled hazard ratio for either fatal or non-fatal severe infection among individuals with any obesity (classes I-III) was 1·7 (1·7-1·8). This association was consistent across different indicators of obesity (BMI, waist circumference, and waist-to-height ratio), demographic and clinical subgroups, and a wide range of infections (non-fatal and fatal, acute and chronic, bacterial and viral [including subtypes], and parasitic and fungal). Applying these risk estimates to global burden of disease data, the population attributable fractions of infection-related deaths due to obesity were estimated at 8·6% (6·6-11·1) in 2018, 15·0% (12·8-17·4) in 2021, and 10·8% (8·6-13·6) in 2023. INTERPRETATION: Adult obesity is a risk factor for infection-related hospitalisations and mortality across diverse pathogen types, populations, and baseline clinical profiles, with evidence suggesting that approximately one in ten infection-related deaths worldwide might be attributable to obesity. FUNDING: Wellcome Trust, Medical Research Council, and Research Council of Finland.
引用
- Nyberg ST, Frank P, Ahmadi-Abhari S, et al. Adult obesity and risk of severe infections: a multicohort study with global burden estimates. Lancet. 2026. PMID: 41679324. doi:10.1016/S0140-6736(25)02474-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。